We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 4,730

Network interference - a legal guide to the commercial risks and rewards of the social media phenomenon
  • Reed Smith LLP
  • European Union, Global, United Kingdom, USA
  • April 22 2014

Social media is a revolution in the way in which corporations communicate with consumers. This White Paper will help you to maximise the huge


Causation Issues in Failure-To-Report Cases - Post-Stengel Precedent
  • Reed Smith LLP
  • USA
  • September 19 2016

As we blogged at the time, we believe that the Ninth Circuit made a historic error in Stengel v. Medtronic Inc., 704 F.3d 1224 (9th Cir., 2013) (en


Defendant Did Not “Fail to Warn” Where It Warned of Exactly What Happened to the Plaintiff’s Artificial Hip
  • Reed Smith LLP
  • USA
  • September 22 2016

We (in its blog-specific singular version) are longstanding country music fans. There is backstory - call us when you are in Philadelphia and we will


If your old photocopier could talk, what would it say? Health plan's used photocopier linked to $1.2 million HIPAA settlement
  • Reed Smith LLP
  • USA
  • August 19 2013

Who knew that photocopiers stored information? Apparently "CBS Evening News" did, and now an April 2010 investigative report has led to a


Off-Label Promotion And The First Amendment Updates
  • Reed Smith LLP
  • USA
  • September 22 2016

Although activity around the Amarin and Pacira cases has settled down, questions regarding the FDA’s position on truthful off-label promotion-and


Wisconsin Preemption Ruling Makes Our Cheese Curdle
  • Reed Smith LLP
  • USA
  • September 20 2016

A federal judge in Wisconsin issued an order a few weeks ago that covers two topics on which we often writenegligence per se and implied preemption


FDA Mandates Black Box Warnings For Opioids And Benzodiazepines
  • Reed Smith LLP
  • USA
  • September 21 2016

The Food and Drug Administration (FDA) recently decided to require so-called “black box warnings” on nearly 400 products, warning of the risks of


HHS Proposes Changes to State Medicaid Fraud Control Unit Rules
  • Reed Smith LLP
  • USA
  • September 22 2016

The Centers for Medicare & Medicaid Services (CMS) and the Office of Inspector General (OIG) have proposed amendments to the regulations governing


Has the Ninth Circuit Criminalized Malpractice, Adulteration, and Off-Label Use?
  • Reed Smith LLP
  • USA
  • September 14 2016

Tell us that that the feds prosecuted a doctor for using a medical device off-label, and the hairs on the back of our neck start to rise and do the


Chantix: A Lesson in Why Litigation Should Not Be Allowed to Get Ahead of Science
  • Reed Smith LLP
  • USA
  • September 8 2016

We here at the DDL Blog try to stay on top of the goings on at the FDA. We’ve learned that on September 14, 2016, the FDA will hold an advisory